Liquid chromatography, in combination with a quadrupole time-of-flight instrument (LC QTOF), with sequential window acquisition of all theoretical fragment-ion spectra (SWATH) acquisition: systematic studies on its use for screenings in clinical and

Liquid chromatography, in combination with a quadrupole time-of-flight instrument (LC QTOF), with sequential window acquisition of all theoretical fragment-ion spectra (SWATH) acquisition: systematic studies on its use for screenings in clinical and

Item

http://www.wikidata.org/entity/Q35347771

Q35347771

about

Emerging proteomic technologies for elucidating context-dependent cellular signaling events: A big challenge of tiny proportions Enhanced acylcarnitine annotation in high-resolution mass spectrometry data: fragmentation analysis for the classification and annotation of acylcarnitines.A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.Nested data independent MS/MS acquisition.Compound identification in forensic toxicological analysis with untargeted LC-MS-based techniques.Successful adaption of a forensic toxicological screening workflow employing nontargeted liquid chromatography-tandem mass spectrometry to water analysis.Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry and Post-run Library Matching.SWATH-MS as a tool for biomarker discovery - from basic research to clinical applications.SWATH-ID: An instrument method which combines identification and quantification in a single analysis.Assessment of simpler calibration models in the development and validation of a fast postmortem multi-analyte LC-QTOF quantitation method in whole blood with simultaneous screening capabilities using SWATH acquisition.Quantitative MS analysis of therapeutic mAbs and their glycosylation for pharmacokinetics study.Practical application of in silico fragmentation based residue screening with ion mobility high-resolution mass spectrometry.High-resolution mass spectrometry in toxicology: current status and future perspectives.Recent (2000-2015) developments in the analysis of minor unknown natural products based on characteristic fragment information using LC-MS.SWATH acquisition mode for drug metabolism and metabolomics investigations.Stepped collisional energy MS(All) : an analytical approach for optimal MS/MS acquisition of complex mixture with diverse physicochemical properties.How Safe Is Safe for Marine Toxins Monitoring?Data-Independent Mass Spectrometry Approach for Screening and Identification of DNA Adducts.Comparison of Post-targeted and Pre-targeted Urine Drug Screening by UHPLC-HR-QTOFMS.In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.A multi-analyte approach to help in assessing the severity of acute poisonings - Development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration.Qualitative and quantitative temporal analysis of licit and illicit drugs in wastewater in Australia using liquid chromatography coupled to mass spectrometry.A Validated Method for the Screening of 320 Forensically Significant Compounds in Blood by LC/QTOF, with Simultaneous Quantification of Selected Compounds.Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).

P2860

Q28081956-F6EDDBAA-0120-42E8-8C19-21D9C7B0D282 Q30915535-093D8DA6-8287-4C49-A1B4-FF6DB965E707 Q30995949-803ED7EC-126E-40A3-B9E9-3DE56DD17DDC Q31096800-498C7586-6164-4A75-94A3-77811681F0BB Q35840290-36B188FB-8F62-44C3-A8D9-AC1F5279B263 Q35899374-2FB57AF8-75F7-4723-913C-E64DD4175042 Q36088120-A1DCA4F2-86B2-4339-8506-D225405F4327 Q36262132-FD93F2D2-3461-4B87-A938-9D8684AABF91 Q36339399-454CCF03-B24A-48D3-B30A-B04FE70A8121 Q38602710-2EB2C3E3-07FE-4174-8514-13E28948533D Q38628086-673F8B49-9C5B-493F-8C32-3A47BF3C742C Q38813225-5B654991-7BB5-40BE-90D8-7B85A13DD54F Q38846184-004EBD6B-C243-4F69-B335-86B820542407 Q38875972-53292972-A080-4C05-A9D5-41B4BF0753B3 Q39557300-A0E98BDF-5C2B-4E10-AF90-B4F9D4987340 Q39754726-C921EF7B-00D9-4291-899F-13FA0F8FC489 Q42211221-2CCE0927-BE85-4809-875F-A3FD88BAA4B4 Q47661718-6A0573F4-EDF5-49B0-A95E-6EF9EB7CDDEC Q48032412-D576681D-6A0F-4395-96C9-D03922AA6A0E Q48103206-E5A69B94-C1D4-401E-937B-40609C0A1C4C Q48289328-4008647E-62DE-4916-A8A9-9CC9447DD022 Q48578302-3E926003-CDD7-4C0F-9651-AA0D5FDB086F Q50062799-922652B9-F4C2-4E34-9DCB-8E0B9B7A4A05 Q52310857-2CE6EF77-3C73-4B1F-B70F-235E08A6C172

P2860

Liquid chromatography, in combination with a quadrupole time-of-flight instrument (LC QTOF), with sequential window acquisition of all theoretical fragment-ion spectra (SWATH) acquisition: systematic studies on its use for screenings in clinical and

Item

http://www.wikidata.org/entity/Q35347771

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu